Uzzo, R;
Bex, A;
Rini, B;
Albiges, L;
Suarez, C;
Donaldson, F;
Asakawa, T;
... Pal, S; + view all
(2017)
A phase III study of atezolizumab (atezo) vs placebo as adjuvant therapy in renal cell carcinoma (RCC) patients (pts) at high risk of recurrence following resection (IMmotion010).
Presented at: 2017 ASCO Annual Meeting I, Chicago (IL), USA.
Preview |
Text
Bex_A phase III study of atezolizumab (atezo) vs placebo_AAM.pdf - Accepted Version Download (385kB) | Preview |
| Type: | Conference item (Presentation) |
|---|---|
| Title: | A phase III study of atezolizumab (atezo) vs placebo as adjuvant therapy in renal cell carcinoma (RCC) patients (pts) at high risk of recurrence following resection (IMmotion010) |
| Event: | 2017 ASCO Annual Meeting I |
| Location: | Chicago (IL), USA |
| Dates: | 2nd-6th June 2017 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS4598 |
| Publisher version: | http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.TPS... |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Surgical Biotechnology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10080390 |
Archive Staff Only
 |
View Item |
